3681 - 3690 of 6255 Results
Title
Year
-
OPENTitle: Molecular estimation of neurodegeneration pseudotime in older brainsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-19622-yBest OA location URL: https://www.nature.com/articles/s41467-020-19622-y.pdfCitation Count: 50
-
OPENTitle: Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-59414-4Best OA location URL: https://www.nature.com/articles/s41598-020-59414-4.pdfCitation Count: 77
-
OPENTitle: Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological studyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-14279-8Best OA location URL: https://escholarship.org/content/qt2n48k3rk/qt2n48k3rk.pdfCitation Count: 382
- Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease2020OPENTitle: Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-66319-9Best OA location URL: https://www.nature.com/articles/s41598-020-66319-9.pdfCitation Count: 21
- Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity2020OPENTitle: Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensityJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-020-16564-3Best OA location URL: https://www.nature.com/articles/s41467-020-16564-3.pdfCitation Count: 138
-
OPENTitle: Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 52Issue #: 5Start Page: 482End Page: 493Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41588-020-0610-9Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/151614623/Genetic_Identification_of_Cell_Types_Underlying_Brain_Complex_BREEN_Published27April2020_GREEN_AAM.pdfCitation Count: 295
-
OPENTitle: Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degenerationJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 387End Page: 397Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0762-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7101073Citation Count: 657
-
OPENTitle: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementiaJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 3Start Page: 379End Page: 386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1Citation Count: 959
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain2020OPENTitle: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 6Start Page: 696End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-020-0635-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7269838Citation Count: 136
-
OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 3